- Home
- TXMD vs KFFB Comparison
TXMD vs KFFB Comparison
Compare TXMD & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TXMD | KFFB |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 36.5M |
| IPO Year | 2012 | 2004 |
Fundamental Metrics
Financial Performance| Metric | TXMD | KFFB |
|---|---|---|
| Price | $2.23 | $4.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 33.0K | 2.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.61 | ★ 109.52 |
| EPS | N/A | ★ 0.08 |
| Revenue | ★ $1,761,000.00 | $15,000.00 |
| Revenue This Year | $427.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $90.64 | ★ $57.50 |
| Revenue Growth | ★ 35.25 | N/A |
| 52 Week Low | $0.72 | $1.96 |
| 52 Week High | $2.95 | $4.98 |
Technical Indicators
Market Signals| Indicator | TXMD | KFFB |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 48.46 |
| Support Level | $1.05 | $4.45 |
| Resistance Level | $2.54 | $4.90 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 40.91 | 20.83 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.